MiNK Therapeutics
Stock Forecast, Prediction & Price Target

MiNK Therapeutics Financial Estimates

MiNK Therapeutics Revenue Estimates

MiNK Therapeutics EBITDA Estimates

MiNK Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$2.70B
 
0%
$0
 
-100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $4.12M
Low: $4.12M
High: $4.12M
avg. 0%
Avg: $4.4M
Low: $4.4M
High: $4.4M
avg. 6.70%
Avg: $70.4M
Low: $70.4M
High: $70.4M
avg. 1500%
Net Income
 
% change YoY
$-23.11M
 
N/A
$-24.77M
 
-7.20%
$-22.45M
 
9.37%
Avg: $-34.76M
Low: $-25.08M
High: $-15.11M
avg. -54.79%
Avg: $-37.30M
Low: $-21.99M
High: $-17.86M
avg. -7.32%
Avg: $-15.11M
Low: $-15.11M
High: $-15.11M
avg. 59.47%
Avg: $343.59K
Low: $343.59K
High: $343.59K
avg. 102.27%
EBITDA
 
% change YoY
$-28.05M
 
N/A
$-30.82M
 
-9.86%
$-22.25M
 
27.81%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $1.64M
Low: $1.64M
High: $1.64M
avg. 0%
Avg: $1.74M
Low: $1.74M
High: $1.74M
avg. 6.70%
Avg: $27.99M
Low: $27.99M
High: $27.99M
avg. 1500.00%
EPS
 
% change YoY
-$0.69
 
N/A
-$0.74
 
-7.24%
-$0.65
 
12.16%
Avg: -$0.57
Low: -$0.73
High: -$0.44
avg. 11.79%
Avg: -$0.58
Low: -$0.64
High: -$0.52
avg. -1.16%
Avg: -$0.44
Low: -$0.44
High: -$0.44
avg. 24.13%
Avg: $0.01
Low: $0.01
High: $0.01
avg. 102.27%
Operating Expenses
 
% change YoY
$18.60M
 
N/A
$30.94M
 
66.33%
$22.92M
 
-25.93%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $7.05M
Low: $7.05M
High: $7.05M
avg. 0%
Avg: $7.52M
Low: $7.52M
High: $7.52M
avg. 6.70%
Avg: $120.43M
Low: $120.43M
High: $120.43M
avg. 1500.00%

FAQ

What is MiNK Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 24.90% in 2025-2028.

We have gathered data from 2 analysts. Their low estimate is -25.08M, average is -34.76M and high is -15.11M.

What is MiNK Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 376.67% in 2025-2028.

We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is MiNK Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 34.26% in 2025-2028.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.73, average is -$0.57 and high is $-0.44.